Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Health resource utilization associated with skeletal-related events: results from a retrospective European study

JJ. Body, J. Pereira, H. Sleeboom, N. Maniadakis, E. Terpos, YP. Acklin, J. Finek, O. Gunther, G. Hechmati, T. Mossman, L. Costa, W. Rogowski, H. Nahi, R. von Moos,

. 2016 ; 17 (6) : 711-21. [pub] 20150808

Jazyk angličtina Země Německo

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17024236

BACKGROUND: Bone complications, also known as skeletal-related events (SREs), are common in patients with bone metastases secondary to advanced cancers. OBJECTIVE: To provide a detailed estimate of the health resource utilization (HRU) burden associated with SREs across eight European countries. METHODS: Eligible patients from centers in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden, and Switzerland with bone metastases or lesions secondary to breast cancer, prostate, or lung cancer or multiple myeloma who had experienced at least one SRE (defined as radiation to bone, long-bone pathologic fracture, other bone pathologic fracture, surgery to bone or spinal cord compression) were entered into this study. HRU data were extracted retrospectively from the patients' charts from 3.5 months before the index SRE until 3 months after the index SRE (defined as an SRE preceded by an SRE-free period of at least 6.5 months). RESULTS: Overall, the mean number of inpatient stays per SRE increased from baseline by approximately 0.5-1.5 stays, with increases in the total duration of inpatient stays of approximately 6-37 days per event. All SREs were associated with substantial increases from baseline in the frequency of procedures and the number of outpatient and day-care visits. CONCLUSIONS: SREs are associated with substantial HRU owing to considerable increases in the number and duration of inpatient stays, and in the number of procedures, outpatient visits, and day-care visits. These data collectively provide a valuable summary of the real-world SRE burden on European healthcare systems.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17024236
003      
CZ-PrNML
005      
20170906124950.0
007      
ta
008      
170720s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10198-015-0716-7 $2 doi
035    __
$a (PubMed)26253584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Body, Jean-Jacques $u CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium. jean-jacques.body@chu-brugmann.be.
245    10
$a Health resource utilization associated with skeletal-related events: results from a retrospective European study / $c JJ. Body, J. Pereira, H. Sleeboom, N. Maniadakis, E. Terpos, YP. Acklin, J. Finek, O. Gunther, G. Hechmati, T. Mossman, L. Costa, W. Rogowski, H. Nahi, R. von Moos,
520    9_
$a BACKGROUND: Bone complications, also known as skeletal-related events (SREs), are common in patients with bone metastases secondary to advanced cancers. OBJECTIVE: To provide a detailed estimate of the health resource utilization (HRU) burden associated with SREs across eight European countries. METHODS: Eligible patients from centers in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden, and Switzerland with bone metastases or lesions secondary to breast cancer, prostate, or lung cancer or multiple myeloma who had experienced at least one SRE (defined as radiation to bone, long-bone pathologic fracture, other bone pathologic fracture, surgery to bone or spinal cord compression) were entered into this study. HRU data were extracted retrospectively from the patients' charts from 3.5 months before the index SRE until 3 months after the index SRE (defined as an SRE preceded by an SRE-free period of at least 6.5 months). RESULTS: Overall, the mean number of inpatient stays per SRE increased from baseline by approximately 0.5-1.5 stays, with increases in the total duration of inpatient stays of approximately 6-37 days per event. All SREs were associated with substantial increases from baseline in the frequency of procedures and the number of outpatient and day-care visits. CONCLUSIONS: SREs are associated with substantial HRU owing to considerable increases in the number and duration of inpatient stays, and in the number of procedures, outpatient visits, and day-care visits. These data collectively provide a valuable summary of the real-world SRE burden on European healthcare systems.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádory kostí $x epidemiologie $x radioterapie $x sekundární $7 D001859
650    _2
$a nádory prsu $x epidemiologie $x patologie $7 D001943
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fraktury kostí $x patologie $7 D050723
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a délka pobytu $x statistika a číselné údaje $7 D007902
650    _2
$a nádory plic $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mnohočetný myelom $7 D009101
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a primární zdravotní péče $x statistika a číselné údaje $7 D011320
650    _2
$a nádory prostaty $x epidemiologie $x patologie $7 D011471
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a komprese míchy $x patologie $7 D013117
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pereira, João $u Universidade Nova de Lisboa, National School of Public Health, Lisbon, Portugal.
700    1_
$a Sleeboom, Harm $u Haga Hospital, The Hague, The Netherlands.
700    1_
$a Maniadakis, Nikos $u Department of Health Services Management, National School of Public Health, Athens, Greece.
700    1_
$a Terpos, Evangelos $u University of Athens School of Medicine, Alexandra University Hospital, Athens, Greece.
700    1_
$a Acklin, Yves Pascal $u Kantonsspital Graubünden, Chur, Switzerland. $7 gn_A_00001031
700    1_
$a Finek, Jindrich $u University Hospital, Pilsen, Czech Republic.
700    1_
$a Gunther, Oliver $u Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
700    1_
$a Hechmati, Guy $u Health Economics, Amgen (Europe) GmbH, Zug, Switzerland.
700    1_
$a Mossman, Tony $u Biostatistics, Amgen Ltd, Cambridge, UK.
700    1_
$a Costa, Luis $u Serviço de Oncologia do Hospital de Santa Maria, Instituto de Medicina Molecular, Lisbon, Portugal.
700    1_
$a Rogowski, Wojciech $u ZOZ MSWiA Z Warmińsko Mazurskim Centrum Onkologii, Olszytn, Poland.
700    1_
$a Nahi, Hareth $u Division of Hematology, Department of Medicine, Karolinska Institute, Huddinge, Stockholm, Sweden.
700    1_
$a von Moos, Roger $u Kantonsspital Graubünden, Chur, Switzerland.
773    0_
$w MED00007432 $t The European journal of health economics HEPAC health economics in prevention and care $x 1618-7601 $g Roč. 17, č. 6 (2016), s. 711-21
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26253584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170906125548 $b ABA008
999    __
$a ok $b bmc $g 1239917 $s 985149
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 17 $c 6 $d 711-21 $e 20150808 $i 1618-7601 $m The European journal of health economics $n Eur J Health Econ $x MED00007432
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace